Yasumi Kitahara

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in <scp>J</scp> apanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial

Masutaka Furue, Yasumi Kitahara, Hideto Akama et al. · The Journal of Dermatology · 2014 · 74 citations

Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists

Ayahisa Watanabe, Junya Nagai, Yoshinori Adachi et al. · Journal of Controlled Release · 2004 · 72 citations

Pharmaceutical Science, Urology, Renal Accumulation +9

Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis

Yoshiya Tanaka, Tsutomu Takeuchi, Hisanori Umehara et al. · Modern Rheumatology · 2017 · 59 citations

Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle‐controlled exploratory trial

Osamu Nemoto, Nobukazu Hayashi, Yasumi Kitahara et al. · The Journal of Dermatology · 2015 · 42 citations

Cisplatin-induced inhibition of receptor-mediated endocytosis of protein in the kidney

Mikihisa Takano, Naoki Nakanishi, Yasumi Kitahara et al. · Kidney International · 2002 · 41 citations · Full text

Urology, Signal Transduction, Cisplatin-induced Inhibition +8